Ivo Schurink

Ivo Schurink is a researcher in the Department of Surgery at Erasmus MC, specializing in liver transplantation and organ preservation technologies. His research focuses on improving graft viability and outcomes through advanced perfusion techniques, including normothermic and hypothermic oxygenated machine perfusion, particularly for donation after circulatory death (DCD) and extended criteria donors.

His research interests span liver graft assessment, ex situ perfusion systems, organoid models, and clinical validation of preservation methods. He actively contributes to translational research aimed at enhancing transplant success rates and expanding the donor pool. His work integrates both experimental and clinical approaches, with a strong emphasis on real-world applicability and cost-effectiveness.

The recent publications highlight a consistent focus on machine perfusion technologies, liver function monitoring (e.g., using indocyanine green), and evidence-based surgical oncology. There is a clear trend toward multicenter validation studies and health economic evaluations, indicating a maturing field and a move toward broader clinical implementation.

Scientific Collaborations and Impact:
He collaborates extensively with leading transplant centers across Europe and contributes to international validation efforts. His work has been cited in major journals and presented in high-impact forums.

While no formal advising or grant information is available in the text, his involvement in multiple collaborative studies suggests participation in funded research projects. His contributions to systematic reviews and clinical trials indicate a strong role in evidence synthesis and trial design.

His research is embedded within a robust surgical and transplant research network at Erasmus MC, likely involving close ties with the liver transplant program and ex vivo perfusion laboratories. The focus on clinical validation and cost-effectiveness suggests integration with health policy and surgical innovation teams.